Background illustration for clinical trials search

Oncology Clinical Trials

Browse 9,272 oncology clinical trials enrolling across the United States and Canada. 218 people applied to oncology studies last month. Search by city or state to find one near you.

Filter
1
New

Animated Storytelling to Promote Colorectal Cancer Screening

for
Colorectal Cancer Screening
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 45+

Code: NCT07522177

Recruiting
New

A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.

for
Pancreatic Ductal Adenocarcinoma, Esophageal Cancer,
Location: Grand Rapids MI, San Antonio TX
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07903415

Phase 1, Recruiting
New

Enhancing ICB Efficacy Through IL-1 Inhibition in TNBC

for
Triple-Negative Breast Cancer (TNBC)
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07698106

Phase 1, Phase 2, Recruiting
New

SumMET: Study of [225Ac]Ac-FL-261 in Participants With Solid Tumors Overexpressing c-MET

for
Solid Tumor, NSCLC, Colorectal Cancer, Head and Neck Cancer,
Location: Minneapolis MN
Sponsor: Full-Life Technologies UK Limited

Sex: All

Age: 18+

Code: NCT07873450

Phase 1, Phase 2, Recruiting
New

Multicenter Study for External Validation of the TB-NET Score

for
Tumor Burden, Neuroendocrine (NE) Tumors
Location: Boston MA, St Louis MO
Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

Sex: All

Age: 18+

Code: NCT07903532

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced Skin Toxicity in People With Pancreatic Cancer

for
Pancreatic Cancer, Skin Toxicities
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07895498

Phase 2, Recruiting
New

SMARCA4/2 Inhibitor for POU2F3-Positive SCLC

for
Small Cell Lung Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT07551635

Phase 2, Recruiting
New

A Phase 1 Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

for
Endometrial Cancer Recurrent, Endometrial Cancer,
Location: Detroit MI, Atlanta GA, Minneapolis MN, Houston TX,
Sponsor: Outpace Bio, Inc.

Sex: Female

Age: 18+

Code: NCT07664735

Phase 1, Recruiting
New

Lungs on Fire: Wildfire Smoke, Incident Diseases, Susceptible Populations, and Community Values in Canada

for
Asthma, Chronic Obstructive Pulmonary Disease (COPD),
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 19 - 70+

Code: NCT07536178

Recruiting
New

A Study of Skipping Radiation Therapy in People With Breast Cancer

for
HER2-positive Breast Cancer, Breast Cancer
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07895511

Recruiting
New

Trial to Evaluate an Educational Video Series for Women in Breast Cancer Treatment

for
Breast Cancer Females, Newly Diagnosed Breast Cancer
Location: Aurora CO, Denver CO, Highlands Ranch CO
Sponsor: University of Colorado, Denver

Sex: Female

Age: 18+

Code: NCT07434817

Recruiting
New

Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial

for
Pancreatic Ductal Adenocarcinoma (PDAC),
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT07787156

Recruiting
New

Navigation Interventions for Patients With Breast Cancer and High-risk Social Determinants of Health

for
Breast Cancer, Cancer of Breast
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: Female

Age: 18+

Code: NCT07781800

Recruiting
New

A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.

for
Advanced Solid Tumors, Recurrent or Progressive Glioblastoma,
Location: Fairfax VA, Tampa FL, Houston TX, Duarte CA
Sponsor: Crossbow Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07779798

Phase 1, Recruiting
New

A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.

for
Ovarian Cancer
Location: Los Angeles CA
Sponsor: Phrontline Biopharma

Sex: All

Age: 18+

Code: NCT07778498

Phase 1, Phase 2, Recruiting
New

Evaluation of a Point-of-Care, AI-Powered Spectroscopy Device for Triage of Suspicious Vulvar Lesions: A Pilot Study

for
Vulvar Intraepithelial Neoplasia, HPV-Independent,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: Female

Age: 18+

Code: NCT07886203

Recruiting
New

Immunotherapy and Nodal-Sparing Irradiation for T-Cell Induction and Unmasking of Tumor Antigenicity in the Microenvironment for Head and Neck Cancer

for
Head and Neck Cancer Squamous Cell Carcinoma
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin

Sex: All

Age: 18+

Code: NCT07773987

Phase 2, Recruiting
New

Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer

for
Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT07667400

Phase 1, Phase 2, Recruiting
New

Hugo™ Robotic Assisted Surgery (RAS) System in Prostatectomy Patients Treated in an ASC Setting

for
Prostate Cancer (Diagnosis)
Location: Columbus OH
Sponsor: Central Ohio Urology Group

Sex: Male

Age: 18+

Code: NCT07875192

Recruiting
New

EHR Intervention to Increase HBOC Genetic Testing

for
Breast Cancer, Ovarian Cancer, Hereditary Cancer Syndrome
Location: New York NY
Sponsor: Columbia University

Sex: Female

Age: 21 - 70+

Code: NCT07876349

Recruiting

What is oncology?

Oncology is the branch of medicine focused on cancer. Cancer itself is not a single disease. It is a family of more than 100 diseases, from breast cancer and lung cancer to blood cancers like leukemia and lymphoma. What they share is the same basic problem: cells that grow and divide without stopping. About 4 in 10 people in the US will be diagnosed with some form of cancer during their lifetime.

Cancer research moves faster than almost any other field of medicine. Cancer drugs made up about 35% of all new FDA drug approvals in 2025, 16 new medicines in one year. The 5 year survival rate for all cancers combined reached 70% for people diagnosed in 2015 to 2021, a first in US history. And survival for metastatic (spread) cancer has doubled since the mid 1990s, from 17% to 35%. Every one of those gains came through clinical trials.

Who can participate in oncology trials?

Do oncology trial participants get paid?

Types of cancer clinical trials

The stages of cancer, and why they matter for trials

How to enroll in a clinical trial for cancer